T

Tecon Biology Co Ltd
SZSE:002100

Watchlist Manager
Tecon Biology Co Ltd
SZSE:002100
Watchlist
Price: 7.81 CNY 0.26% Market Closed
Market Cap: ¥10.7B

Tecon Biology Co Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Tecon Biology Co Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
T
Tecon Biology Co Ltd
SZSE:002100
EPS (Diluted)
¥0
CAGR 3-Years
N/A
CAGR 5-Years
-28%
CAGR 10-Years
1%
Tongwei Co Ltd
SSE:600438
EPS (Diluted)
-¥1
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Heilongjiang Agriculture Co Ltd
SSE:600598
EPS (Diluted)
¥0
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
6%
B
Beijing Dabeinong Technology Group Co Ltd
SZSE:002385
EPS (Diluted)
¥0
CAGR 3-Years
N/A
CAGR 5-Years
-21%
CAGR 10-Years
-5%
New Hope Liuhe Co Ltd
SZSE:000876
EPS (Diluted)
¥0
CAGR 3-Years
N/A
CAGR 5-Years
-34%
CAGR 10-Years
-9%
Jiangxi Zhengbang Technology Co Ltd
SZSE:002157
EPS (Diluted)
¥0
CAGR 3-Years
88%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tecon Biology Co Ltd
Glance View

Market Cap
10.7B CNY
Industry
Food Products

Tecon Biology Co Ltd has carved its niche in the rapidly evolving biotechnology sector, specializing in the development and production of bio-based products and solutions. At its core, the company leverages advanced biological science to create environmentally friendly products that satisfy a range of industrial needs. Operating at the intersection of science and sustainability, Tecon has focused its efforts on the use of microbial fermentation technology and genetic engineering to produce bio-products that support agricultural, pharmaceutical, and environmental applications. By advancing proprietary technological capabilities, the company has demonstrated a commitment to not only commercial success but also environmental stewardship, recognizing the increasing global emphasis on sustainable business practices. The company's financial model is centered around translating cutting-edge biological research into commercially viable products. Tecon Biology generates revenue by licensing its biotechnological innovations to major agricultural and pharmaceutical firms that seek sustainable and cost-effective alternatives to traditional chemical-based products. Additionally, Tecon manufactures and sells its own branded line of bio-products, such as bio-fertilizers and enzyme solutions, directly to end-users both domestically and internationally. This dual approach allows the company to capitalize on the growing demand for sustainable solutions while maintaining diverse revenue streams, thereby enhancing its resilience in the competitive biotech industry. Through strategic collaborations and continuous innovation, Tecon Biology has established itself as a formidable player in the global market, poised to address some of the biggest challenges facing the world today.

Intrinsic Value
11.46 CNY
Undervaluation 32%
Intrinsic Value
Price ¥7.81
T

See Also

What is Tecon Biology Co Ltd's EPS (Diluted)?
EPS (Diluted)
0.3 CNY

Based on the financial report for Sep 30, 2025, Tecon Biology Co Ltd's EPS (Diluted) amounts to 0.3 CNY.

What is Tecon Biology Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
1%

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett